Inceptor Bio Takes a Major Step in Clinical Trials for Cancer Therapy with New Funding Inceptor Bio has initiated clinical trials for IB-T101, a promising cancer treatment for ccRCC, supported by $21M funding. This milestone heralds a new era in cancer therapies.

Inceptor Bio Takes a Major Step in Clinical Trials for Cancer Therapy with New Funding #United_States #Research_Triangle_Park #Inceptor_Bio #IB-T101 #ccRCC

Inceptor Bio and GRIT Bio Join Forces to Revolutionize CAR-T Cancer Treatment Inceptor Bio and GRIT Bio forge a strategic alliance focused on advancing IB-T101, a cutting-edge CAR-T therapy targeting solid tumors, promising a transformative approach.

Inceptor Bio and GRIT Bio Join Forces to Revolutionize CAR-T Cancer Treatment #United_States #CAR-T_therapy #Inceptor_Bio #GRIT_Bio #Morrisville